Prof. Dr. med. Alexander Mustea
gynecology and gynecological oncology
gynecology and gynecological oncology
Overview
Country, City
Germany, Bonn
Health facility
University Hospital Bonn
Medical unit
Department of gynecology and gynecological oncology
About the doctor
Skills & Expertise
cancer
ovarian cancer
endometrial
tumor
endometrial cancer
carcinoma
cervical
oncology
cervical cancer
gynecology
epithelial
vulvar cancer
recurrent ovarian cancer
epithelial ovarian cancer
chemotherapy
pelvic
malignant
sarcoma
breast cancer
ovarian carcinoma
breast
fibroids
uterus
leiomyosarcoma
carcinoma cells
malignancies
peritoneal cancer
tumor dissemination
ovarian cancer cells
lymph node
vulvar squamous cell
vaginal
ovary
cell carcinoma
squamous cell carcinoma
fallopian tube
brca mutation
endometrial carcinoma
uterine leiomyosarcoma
hifu uterine
gynecological sarcoma
vaginal adenocarcinoma
epithelial carcinoma
ascitesderived exosomes
ewings sarcoma
papilloma virus
mammary carcinoma
cervical carcinoma
urothelial carcinoma
vulva
Resume
CV (Curriculum Vitae)
Education
- Studied human medicine
- Obtaining a license for medical practice
- Obtaining specialization in gynecology
- Received additional specialization in gynecological oncology
Experience
- Charite University Hospital in Berlin
- Deputy Director and Senior Consultant, Department of gynecology and obstetrics at the Greifswald University Medical Center
- Founded the first gynecological tumor treatment center in Mecklenburg-Vorpommern at the Greifswald University Medical Center
- Visiting professor at the Nikolae Testemitsanu Medical University in Chisinau
- 2019 Director, Department of gynecology and gynecological oncology at the University Hospital Bonn
Awards & Memberships
- Listed in the FOCUS list of doctors for gynecological tumors
Languages
English
German
Publications
TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target.
September, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.
15 August, 2023
Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ).
August, 2023
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Alexander Mustea?
The primary specialization of the doctor is gynecology and gynecological oncology.
What is the experience of the specialist?
Prof. Dr. med. Alexander Mustea has been practicing for more than 5 years.
Prof. Dr. med. Alexander Mustea
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Alexander Mustea